SCHEMBL5268975

SCHEMBL5268975

CCCCOC(=O)CC(=O)OCCC

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
NAAA Q02083 1/20 0.56
FAAH O00519 2/20 0.55
ATM Q13315 1/20 0.52
MGAM O43451 1/20 0.50
GAA P10253 1/20 0.50
SI P14410 1/20 0.50
MGAM2 Q2M2H8 1/20 0.50
DGKA P23743 1/20 0.50
TSHR P16473 3/20 0.48
HPGD P15428 1/20 0.48
RAD52 P43351 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
EPHX1 P07099 1/20 0.47
ACHE P22303 5/20 0.45
HCAR2 Q8TDS4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL152233 0.95 ALDH1A1 (0.61) ALDH1A1NAAAFAAHATMMGAM
SCHEMBL18320247 0.93 NAAA (0.65) ALDH1A1NAAAFAAHMGAMGAA
SCHEMBL7611107 0.93 ALDH1A1 (0.58) ALDH1A1NAAAFAAHATMMGAM
Butane SCHEMBL6048840 0.93 ALDH1A1 (0.58) ALDH1A1NAAAFAAHATMMGAM
SCHEMBL29093455 0.93 ALDH1A1 (0.58) ALDH1A1NAAAFAAHATMMGAM
SCHEMBL18320240 0.91 NAAA (0.69) NAAAFAAHDGKATSHRRAD52
SCHEMBL18319913 0.91 NAAA (0.68) ALDH1A1NAAAFAAHATMMGAM
SCHEMBL240282 0.90 MGAM (0.60) ALDH1A1NAAAFAAHMGAMGAA
SCHEMBL3282093 0.89 ALDH1A1 (0.56) ALDH1A1NAAAFAAHATMMGAM
SCHEMBL1205859 0.88 MGAM (0.68) ALDH1A1NAAAFAAHATMMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12359017-B2 Method for producing a rigid polyurethane foam BASF SE (DE) 2025-07-15 US claimed
EP-4116351-A1 METHOD FOR MANUFACTURING POLYURETHANE RIGID FOAMS BASF SE (DE) 2023-01-11 EP claimed
EP-3310835-B1 METHOD FOR MANUFACTURING POLYURETHANE RIGID FOAMS BASF SE (DE) 2022-09-07 EP claimed
US-20180186924-A1 METHOD FOR PRODUCING A RIGID POLYURETHANE FOAM BASF SE (DE) 2018-07-05 US claimed
EP-3310835-A1 METHOD FOR PRODUCING A RIGID POLYURETHANE FOAM BASF SE (DE) 2018-04-25 EP claimed
WO-2016202912-A1 METHOD FOR PRODUCING A RIGID POLYURETHANE FOAM BASF SE (DE) 2016-12-22 WO claimed
US-9365596-B2 Method for preparing quaternary phosphonium salts MICROVAST POWER SYSTEMS CO., LTD. (CN) 2016-06-14 US claimed
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS MICROVAST POWER SYSTEMS CO., LTD. (CN) 2015-06-18 US claimed
US-12359017-B2 Method for producing a rigid polyurethane foam BASF SE (DE) 2025-07-15 US disclosed
EP-4116351-A1 METHOD FOR MANUFACTURING POLYURETHANE RIGID FOAMS BASF SE (DE) 2023-01-11 EP disclosed
EP-3310835-B1 METHOD FOR MANUFACTURING POLYURETHANE RIGID FOAMS BASF SE (DE) 2022-09-07 EP disclosed
US-20180186924-A1 METHOD FOR PRODUCING A RIGID POLYURETHANE FOAM BASF SE (DE) 2018-07-05 US disclosed
EP-3310835-A1 METHOD FOR PRODUCING A RIGID POLYURETHANE FOAM BASF SE (DE) 2018-04-25 EP disclosed
WO-2016202912-A1 METHOD FOR PRODUCING A RIGID POLYURETHANE FOAM BASF SE (DE) 2016-12-22 WO disclosed
WO-2003073849-A1 DIESTER DICARBOXYLATE ANTIMICROBIAL COMPOSITIONS AND METHODS EMPLOYING THEM ECOLAB INC. (US) 2003-09-12 WO disclosed
US-20030087786-A1 High concentration monoester peroxy dicarboxylic acid compositions, use solutions, and methods employing them ECOLAB USA INC. 2003-05-08 US disclosed
US-20030021853-A1 In situ mono-or diester dicarboxylate compositions ECOLAB USA INC. 2003-01-30 US disclosed
WO-2003005817-A2 HIGH CONCENTRATION MONOESTER PEROXY DICARBOXYLIC ACID COMPOSITIONS, USE SOLUTIONS, AND METHODS EMPLOYING THEM ECOLAB INC. (US) 2003-01-23 WO disclosed
WO-2003005818-A1 IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS ECOLAB INC. (US) 2003-01-23 WO disclosed
US-20020168422-A1 Two solvent antimicrobial compositions and methods employing them ECOLAB USA INC. 2002-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030021853-A1 In situ mono-or diester dicarboxylate compositions DDC, HCAR3, ACMSD ALDH1A1 590/4885NAAA 88/4885FAAH 900/4885
US-20020168422-A1 Two solvent antimicrobial compositions and methods employing them TAS2R50, HDHD5, CEL ALDH1A1 2741/4885NAAA 455/4885FAAH 1915/4885
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS PHPT1, PHOSPHO1, PTEN ALDH1A1 4827/4885NAAA 682/4885FAAH 2804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.